Pharmacological prevention in cardio-oncology: from bench-to-bedside
Ashot Avagimyan, Nana Pogosova, Federica Fogacci, О. И. Уразова, Zinaida Jndoyan, Lilia R. Mirzoyan, Gayane Avetisyan, Marco Bernardi, Luigi Spadafora, Davood Shafie, Francesco Perone, Marzieh Taheri, Arrigo F.G. Cicero, Giuseppe Biondi‐Zoccai, Riccardo Asteggiano, Rosalinda Madona, Raffaele De Caterina, Nizal Sarrafzadegan
Topics & Concepts
MedicineCardiotoxicityEplerenoneHeart failureCardioprotectionSpironolactoneIntensive care medicineCarvedilolClinical trialPharmacologyEjection fractionAtorvastatinOxidative stressDapagliflozinProstate cancerCancerBioinformaticsDiabetes mellitusAldosteroneAdverse effectInternal medicineDrugValsartanCardiologyStatinEzetimibeCardiomyopathyOncologyMetabolic syndromeDiastolic functionMineralocorticoid receptorChemotherapy-induced cardiotoxicity and mitigationCancer, Lipids, and MetabolismCancer, Stress, Anesthesia, and Immune Response